Team AssistENT compares the potential results of N-Stent in nasal obstruction sufferers to what contact lenses have done for glasses-wearers, reports Forbes.
“AssistENT is about to begin a clinical trial approved by the Johns Hopkins Institutional Review Boards centering on comparisons between our N-Stent breathing aid and commercially available sleep aid dilators,” Austin said. “While a clinical trial is not necessary for our class of technology, we aim to concretely demonstrate N-Stent’s efficacy, safety and usability to nasal obstruction patients and the medical community, including the general practitioners, ENTs, allergists, dentists and sleep specialists who see value in our product and need clinical data to confidently recommend or offer samples to their patients.”
